Notice of Meeting, 22685 [2014-09175]
Download as PDF
<![CDATA[
22685
Federal Register / Vol. 79, No. 78 / Wednesday, April 23, 2014 / Notices
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
per year
Data collection activity
Total ...................................................................................................
Number of
responses per
respondent
33
Hours per
response
1
Total burden
hours
1
33
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Data collection activity
Total burden
hours
Average hourly wage rate
Total cost
burden
In-depth Interviews with external stakeholders:
• Acute Care Hospital Settings ................................................................
• Ambulatory Surgical Centers ................................................................
• ESRD facilities ......................................................................................
• Long Term Care Settings .....................................................................
9
8
8
8
9
8
8
8
$34.33*
34.33*
34.33*
34.33*
$309.00
275.00
275.00
275.00
Total ...................................................................................................
33
na
na
1,134.00
* Based upon May 2012 National Occupational Employment and Wage Estimates for Epidemiologists, retrieved from https://www.bls.gov/oes/
current/oes_nat.htm#19-0000 on February 20, 2014.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: April 9, 2014.
Richard Kronick,
Director.
[FR Doc. 2014–09172 Filed 4–22–14; 8:45 am]
wreier-aviles on DSK5TPTVN1PROD with NOTICES
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
VerDate Mar<15>2010
15:37 Apr 22, 2014
Jkt 232001
ACTION:
Notice.
In accordance with section
10(a)(2) of the Federal Advisory
Committee Act (5 U.S.C. App. 2),
announcement is made of an Agency for
Healthcare Research and Quality
(AHRQ) Special Emphasis Panel (SEP)
meeting on ‘‘AHRQ RFA–HS14–007,
Patient-Centered Outcomes Research
(PCOR) for Deliberative Approaches:
Patient and Consumer Input for
Implementing Evidence-Based Health
Care (R21)’’. Each SEP meeting will
commence in open session before
closing to the public for the duration of
the meeting.
DATES: May 15–16, 2014 (Open on May
15 from 8:00 a.m. to 8:30 a.m. and
closed for the remainder of the meeting).
ADDRESSES: Gaithersburg Marriott
Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg,
Maryland 20878.
FOR FURTHER INFORMATION CONTACT:
Anyone wishing to obtain a roster of
members, agenda or minutes of the nonconfidential portions of this meeting
should contact:
Mrs. Bonnie Campbell,
Committee Management Officer,
Office of Extramural Research,
Education and Priority Populations,
AHRQ,
540 Gaither Road, Room 2038,
Rockville, Maryland 20850,
Telephone: (301) 427–1554.
Agenda items for this meeting are
subject to change as priorities dictate.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the Agency for
Healthcare Research and Quality
(AHRQ), and agree to be available, to
SUMMARY:
PO 00000
Frm 00068
Fmt 4703
Sfmt 9990
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Each SEP meeting will commence in
open session before closing to the public
for the duration of the meeting. The SEP
meeting referenced above will be closed
to the public in accordance with the
provisions set forth in 5 U.S.C. App. 2,
section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6). Grant applications for
the ‘‘AHRQ RFA–HS14–007, PatientCentered Outcomes Research (PCOR) for
Deliberative Approaches: Patient and
Consumer Input for Implementing
Evidence-Based Health Care (R21)’’ are
to be reviewed and discussed at this
meeting. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Dated: April 9, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014–09175 Filed 4–22–14; 8:45 am]
BILLING CODE 4160–90–P
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 79, Number 78 (Wednesday, April 23, 2014)]
[Notices]
[Page 22685]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-09175]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (5 U.S.C. App. 2), announcement is made of an Agency for
Healthcare Research and Quality (AHRQ) Special Emphasis Panel (SEP)
meeting on ``AHRQ RFA-HS14-007, Patient-Centered Outcomes Research
(PCOR) for Deliberative Approaches: Patient and Consumer Input for
Implementing Evidence-Based Health Care (R21)''. Each SEP meeting will
commence in open session before closing to the public for the duration
of the meeting.
DATES: May 15-16, 2014 (Open on May 15 from 8:00 a.m. to 8:30 a.m. and
closed for the remainder of the meeting).
ADDRESSES: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, Maryland 20878.
FOR FURTHER INFORMATION CONTACT: Anyone wishing to obtain a roster of
members, agenda or minutes of the non-confidential portions of this
meeting should contact:
Mrs. Bonnie Campbell,
Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ,
540 Gaither Road, Room 2038,
Rockville, Maryland 20850,
Telephone: (301) 427-1554.
Agenda items for this meeting are subject to change as priorities
dictate.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
the Agency for Healthcare Research and Quality (AHRQ), and agree to be
available, to conduct on an as needed basis, scientific reviews of
applications for AHRQ support. Individual members of the Panel do not
attend regularly-scheduled meetings and do not serve for fixed terms or
a long period of time. Rather, they are asked to participate in
particular review meetings which require their type of expertise.
Each SEP meeting will commence in open session before closing to
the public for the duration of the meeting. The SEP meeting referenced
above will be closed to the public in accordance with the provisions
set forth in 5 U.S.C. App. 2, section 10(d), 5 U.S.C. 552b(c)(4), and 5
U.S.C. 552b(c)(6). Grant applications for the ``AHRQ RFA-HS14-007,
Patient-Centered Outcomes Research (PCOR) for Deliberative Approaches:
Patient and Consumer Input for Implementing Evidence-Based Health Care
(R21)'' are to be reviewed and discussed at this meeting. The grant
applications and the discussions could disclose confidential trade
secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Dated: April 9, 2014.
Richard Kronick,
AHRQ Director.
[FR Doc. 2014-09175 Filed 4-22-14; 8:45 am]
BILLING CODE 4160-90-P
